Oncology Resource Center
Click on the subcategory below to find drug monographs for that particular area.
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
The Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Keytruda (pembrolizumab) for the treatment of metastatic non-small cell lung cancer (NSCLC) in patients whose disease has progressed after other treatments and with tumors that express PD-L1.
A study of more than five million Swedish men and women suggests that greater height may mean greater risk of cancer.
Only about one-third of women receive genetic counseling before they undergo testing for BRCA mutations, and patients who receive genetic counseling beforehand display better knowledge of the process and possible results.
Surgical intervention for a non-lung cancer diagnosis is rare following low-dose computed tomography (CT) screening for lung cancer.
A new study has identified significant differences between non-small-cell lung cancer patients who smoke and those who don't.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Featured courses from myCME
Led by renowned faculty Program Director Christopher G. Willett, MD, this review focuses on therapies ...
This activity is designed to change health provider attitudes on chronic pain and willingness to ...
Among the many issues clinicians face today, staying current with advances in medicine is becoming ...